DBV Technologies
DBVT
67 hedge funds and large institutions have $862M invested in DBV Technologies in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 7 closing their positions.
5,075% more call options, than puts
Call options by funds: $207K | Put options by funds: $4K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
14% more capital invested
Capital invested by funds: $758M → $862M (+$103M)
3% more funds holding
Funds holding: 65 → 67 (+2)
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$12M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$8.68M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.85M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.57M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$6.42M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$5.52M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.95M |
| 4 |
Millennium Management
New York
|
-$2.04M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.25M |
DBVT Hedge Fund Activity: Q3 2016 in Review
67 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in DBV Technologies (DBVT) for Q3 2016, worth a combined $862M — up 14% from $758M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DBVT positions and 7 closed out — a net gain of 2 holders — while 16 added to existing stakes and 24 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $12M. The largest seller was JP Morgan Chase, cutting an estimated $6.42M.
- 67 institutional investors held DBV Technologies (DBVT) as of Q3 2016, up from 65 in Q2 2016.
- Funds reported $862M of DBV Technologies stock for Q3 2016, up 14% quarter-over-quarter.
- 9 funds opened new DBV Technologies positions in Q3 2016 and 7 closed out, a net change of +2 holders.
- The largest DBV Technologies buyer in Q3 2016 was OrbiMed, an estimated $12M added.
- The largest DBV Technologies seller in Q3 2016 was JP Morgan Chase, an estimated $6.42M sold.
Based on aggregated 13F filings for Q3 2016.